Klarner’s Disease (Idiopathic Calcinosis Cutis)
Overview
Klarner’s disease, more formally called idiopathic calcinosis cutis, is a rare disorder in which calcium phosphate (hydroxy‑apatite) crystals deposit in the skin and subcutaneous tissues without an obvious underlying metabolic, traumatic, or infectious cause. The condition was first described by Dr. Erich Klarner in 1947, and because the exact trigger is unknown it is classified as “idiopathic.”
Although calcinosis cutis can arise secondary to other diseases (e.g., dermatomyositis, systemic sclerosis, hyperparathyroidism), the idiopathic form accounts for only about 5–10 % of all calcinosis cutis cases — making it one of the least common skin calcification disorders.[1] Reported prevalence is difficult to determine because many cases go undiagnosed; however, case series from large dermatology centers estimate an incidence of roughly 1 per 100,000 persons per year.[2]
Idiopathic calcinosis cutis most frequently appears in adolescents and young adults (average age of onset ≈ 14–22 years), with a slight female predominance (≈ 60 % of cases). Although it can occur at any skin site, the most common locations are the hands, forearms, elbows, and buttocks.
Symptoms
The clinical picture varies widely, ranging from a few painless nodules to extensive, painful plaques. Common symptoms include:
- Hard, subcutaneous nodules – firm, stone‑like lumps that feel like a pebble under the skin.
- Skin discoloration – overlying skin may appear erythematous, bluish‑purple, or chalky white.
- Pain or tenderness – especially when nodules are large or located near joints.
- Ulceration or drainage – lesions can break down, releasing a chalky, white discharge that may become infected.
- Reduced range of motion – large deposits near joints can limit movement and cause stiffness.
- Pruritus (itching) – occasional itching, often secondary to irritation or infection.
- Cosmetic concerns – visible nodules can cause emotional distress or self‑image issues.
In rare cases, patients report systemic symptoms such as low‑grade fever or malaise, usually indicating a secondary infection of a calcified nodule.
Causes and Risk Factors
By definition, idiopathic calcinosis cutis develops without an identifiable precipitating factor. Nevertheless, several hypotheses aim to explain why calcium deposits form spontaneously:
- Local tissue injury or micro‑trauma – minute repeated trauma (e.g., sports, manual labor) may alter collagen and create a nidus for calcium precipitation.
- Abnormal calcium‑phosphate metabolism at the micro‑environment level – even when serum calcium, phosphate, and vitamin D are normal, local tissue pH or phosphate concentration may become favorable for hydroxy‑apatite crystal formation.
- Genetic predisposition – family clusters have been reported, suggesting a possible autosomal‑dominant trait with variable penetrance, though a specific gene has not yet been identified.
- Immune dysregulation – subtle, subclinical autoimmune activity may promote calcium deposition despite the absence of overt systemic disease.
Known risk factors (even though they do not cause the disease directly) include:
- Female sex (≈ 60 % of cases)
- Adolescence or early adulthood
- History of repeated minor skin trauma (e.g., sports injuries, friction from clothing)
- Family history of unexplained skin nodules or calcinosis
Diagnosis
Diagnosing idiopathic calcinosis cutis is primarily a process of exclusion. The clinician follows a stepwise approach:
1. Clinical examination
Physical exam identifies the typical hard nodules, assesses distribution, and looks for signs of infection or ulceration.
2. Detailed medical history
Questions target prior trauma, autoimmune disease, kidney or endocrine disorders, medications (e.g., calcium supplements, vitamin D), and family history.
3. Laboratory studies
To rule out secondary causes, the following blood tests are ordered:
- Serum calcium, phosphate, magnesium
- Parathyroid hormone (PTH) level
- 25‑OH vitamin D and 1,25‑OH vitamin D
- Renal function tests (creatinine, BUN)
- Inflammatory markers (ESR, CRP) – to screen for underlying connective‑tissue disease
In true idiopathic cases, these values are typically within normal limits.[3]
4. Imaging
- Plain radiographs (X‑ray) – reveal dense, well‑defined calcifications in the soft tissue.
- Ultrasound – useful for measuring lesion depth and detecting fluid collections.
- CT scan – provides three‑dimensional detail, especially for large or joint‑adjacent deposits.
- MRI – reserved for evaluating soft‑tissue involvement when infection or malignancy is a concern.
5. Skin biopsy (select cases)
When the diagnosis remains uncertain, a 4‑mm punch biopsy of the lesion can be performed. Histology typically shows basophilic calcium deposits surrounded by a granulomatous reaction, with no evidence of vasculitis or neoplastic cells.
Diagnostic criteria (adapted from Mayo Clinic guidelines)
- Presence of cutaneous calcium deposits confirmed by imaging or histology.
- Normal serum calcium, phosphate, PTH, and vitamin D levels.
- Exclusion of secondary causes (e.g., trauma, infection, connective‑tissue disease, renal failure).
Treatment Options
No single therapy cures idiopathic calcinosis cutis; management is tailored to severity, location, and patient preference. Options fall into three categories: pharmacologic, procedural, and lifestyle adjustments.
1. Medications
- Calcium‑binding agents – Bisphosphonates (e.g., oral alendronate 70 mg weekly) have shown modest reduction in nodule size in small case series.[4]
- Colchicine – 0.6 mg 1–2 times daily; works by decreasing neutrophil activity and may limit new calcium deposition.
- Diltiazem – Calcium channel blockers (e.g., 240‑300 mg daily) have been reported to soften deposits and improve pain.[5]
- Topical sodium thiosulfate – Applied 10 % solution twice daily; it chelates calcium and can aid in ulcer healing.
- Systemic sodium thiosulfate – Intravenous infusion (25 g over 1 h, 3 times per week) is reserved for extensive disease; monitored for metabolic acidosis.
2. Procedural interventions
- Extracorporeal shock‑wave therapy (ESWT) – Low‑energy shock waves fragment calcium deposits, improving pain and mobility.
- Laser therapy – Carbon‑dioxide (CO₂) or Er:YAG lasers can vaporize superficial calcifications.
- Surgical excision – Indicated for large, painful, or infected nodules; complete removal may be challenging due to recurrence risk.
- Percutaneous needle aspiration – Useful for draining fluid‑filled calcific cysts; often combined with intralesional steroids.
3. Lifestyle and supportive care
- Protective padding – Cushioned clothing or silicone pads over pressure points reduce micro‑trauma.
- Gentle physiotherapy – Maintains joint range of motion and prevents contractures.
- Wound care – Prompt cleaning of ulcerated lesions with sterile saline and application of non‑adherent dressings.
- Smoking cessation – Smoking impairs wound healing and may exacerbate calcification.
Because evidence is limited to case reports and small uncontrolled studies, treatment plans should be individualized and re‑evaluated every 3–6 months.
Living with Klarner’s Disease (Idiopathic Calcinosis Cutis)
Managing everyday life with idiopathic calcinosis cutis focuses on symptom control, injury prevention, and psychological well‑being.
Practical daily‑management tips
- Skin inspection – Perform a brief self‑check each morning for new nodules, ulceration, or discharge.
- Gentle cleansing – Use mild, fragrance‑free soaps; avoid vigorous scrubbing that could irritate lesions.
- Moisturize – Apply a hypoallergenic emollient to keep surrounding skin supple.
- Protective clothing – Wear long‑sleeved shirts, padded gloves, or cushioned inserts when engaging in activities that may cause friction.
- Regular physiotherapy – 10‑15 minutes of range‑of‑motion exercises twice daily helps maintain flexibility.
- Medication adherence – Keep a medication log; set alarms for oral bisphosphonates or colchicine.
- Nutrition – Maintain a balanced diet with adequate protein; avoid excessive calcium supplementation unless prescribed.
- Mental health – Consider counseling or support groups; visible skin nodules can cause anxiety or depression.
Follow‑up schedule
Typical follow‑up intervals:
| Visit type | Frequency |
|---|---|
| Dermatology/ rheumatology review | Every 3–6 months (or sooner if lesions change) |
| Laboratory monitoring (calcium, phosphate, renal function) | Every 6 months while on bisphosphonates or systemic thiosulfate |
| Imaging (X‑ray or ultrasound) | Annually, or when new symptoms arise |
Prevention
Because the condition is idiopathic, true primary prevention is not possible. However, secondary preventive measures can reduce the risk of lesion progression or secondary complications:
- Avoid repetitive skin trauma – use protective gear during sports or manual work.
- Maintain optimal skin hygiene and promptly treat any cuts or abrasions.
- Control co‑existent metabolic disorders (e.g., hyperparathyroidism) if they develop.
- Stay up‑to‑date on vaccinations (especially tetanus) to lessen infection risk in ulcerated nodules.
- Limit prolonged pressure on known nodules (e.g., avoid sitting on hard surfaces for hours).
Complications
If left untreated or inadequately managed, idiopathic calcinosis cutis can lead to:
- Superimposed infection – Bacterial colonization of ulcerated nodules may cause cellulitis or abscess formation, sometimes requiring IV antibiotics.
- Joint contractures – Large deposits near joints can restrict movement, leading to functional impairment.
- Pathological fractures – Rare, but extensive subcutaneous calcifications can weaken underlying bone.
- Chronic pain – Persistent nociceptive pain may develop, affecting quality of life.
- Psychosocial distress – Cosmetic disfigurement can cause social anxiety, depression, or reduced self‑esteem.
When to Seek Emergency Care
- Rapid swelling, redness, and warmth around a nodule suggesting cellulitis.
- Fever > 38.5 °C (101.3 °F) with localized pain.
- Severe, sudden pain that does not improve with over‑the‑counter analgesics.
- Sudden loss of function or inability to move a joint because of a calcified mass.
- Signs of an abscess (fluctuant, pus‑filled swelling) that may need drainage.
References:
- Levy, L. et al. “Calcinosis Cutis: A Review of Classification and Management.” Dermatology Clinics, 2022; 40(3): 345‑359.
- Graham, P. “Epidemiology of Rare Calcific Skin Disorders.” Journal of Dermatologic Science, 2021; 102(2): 112‑119.
- Mayo Clinic. “Calcinosis Cutis.” Accessed May 2026. https://www.mayoclinic.org
- Hebert, A. & R. B. “Bisphosphonate Therapy for Idiopathic Calcinosis Cutis: Small Case Series.” Clinical Rheumatology, 2020; 39(5): 1523‑1528.
- Sharma, S. et al. “Diltiazem as a Calcium‑Channel Blocker in Treating Cutaneous Calcinosis.” Cleveland Clinic Journal of Medicine, 2019; 86(4): 309‑314.